MedCap AB (publ) (MCAP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MedCap AB (publ) (MCAP) has a cash flow conversion efficiency ratio of 0.034x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr51.70 Million ≈ $5.56 Million USD) by net assets (Skr1.53 Billion ≈ $164.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MedCap AB (publ) (MCAP) market capitalisation for the company's overall valuation and market capitalisation.
MedCap AB (publ) - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how MedCap AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
MedCap AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedCap AB (publ) ranked by their cash flow conversion efficiency. Explore MedCap AB (publ) (MCAP) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang JW Precision Machinery Co.Ltd
SHE:300984
|
0.004x |
|
Hanma Technology Group Co Ltd
SHG:600375
|
-0.016x |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
N/A |
|
Chongqing Road & Bridge Co Ltd
SHG:600106
|
0.011x |
|
Anhui Estone Materials Technology Co Ltd
SHG:688733
|
-0.014x |
|
Guangzhou Pearl River Piano Group Co Ltd
SHE:002678
|
-0.021x |
|
Blue Sail Medical Co Ltd
SHE:002382
|
-0.007x |
|
Beijing UniStrong Science & Technology Co Ltd
SHE:002383
|
0.020x |
Annual Cash Flow Conversion Efficiency for MedCap AB (publ) (2007–2025)
The table below shows the annual cash flow conversion efficiency of MedCap AB (publ) from 2007 to 2025. View MedCap AB (publ) (MCAP) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.46 Billion ≈ $157.00 Million |
Skr342.70 Million ≈ $36.88 Million |
0.235x | -15.94% |
| 2024-12-31 | Skr1.29 Billion ≈ $138.63 Million |
Skr360.00 Million ≈ $38.74 Million |
0.279x | +25.89% |
| 2023-12-31 | Skr1.03 Billion ≈ $110.53 Million |
Skr228.00 Million ≈ $24.54 Million |
0.222x | +122.94% |
| 2022-12-31 | Skr858.70 Million ≈ $92.41 Million |
Skr85.50 Million ≈ $9.20 Million |
0.100x | -40.27% |
| 2021-12-31 | Skr697.70 Million ≈ $75.08 Million |
Skr116.30 Million ≈ $12.52 Million |
0.167x | -13.19% |
| 2020-12-31 | Skr602.00 Million ≈ $64.78 Million |
Skr115.60 Million ≈ $12.44 Million |
0.192x | -10.50% |
| 2019-12-31 | Skr332.80 Million ≈ $35.81 Million |
Skr71.40 Million ≈ $7.68 Million |
0.215x | -35.16% |
| 2018-12-31 | Skr273.80 Million ≈ $29.47 Million |
Skr90.60 Million ≈ $9.75 Million |
0.331x | +224.47% |
| 2017-12-31 | Skr267.70 Million ≈ $28.81 Million |
Skr27.30 Million ≈ $2.94 Million |
0.102x | -63.41% |
| 2016-12-31 | Skr292.29 Million ≈ $31.45 Million |
Skr81.46 Million ≈ $8.77 Million |
0.279x | +675.70% |
| 2015-12-31 | Skr308.15 Million ≈ $33.16 Million |
Skr-14.92 Million ≈ $-1.61 Million |
-0.048x | -701.63% |
| 2014-12-31 | Skr280.63 Million ≈ $30.20 Million |
Skr2.26 Million ≈ $243.00K |
0.008x | +106.43% |
| 2013-12-31 | Skr221.92 Million ≈ $23.88 Million |
Skr865.00K ≈ $93.09K |
0.004x | -98.02% |
| 2012-12-31 | Skr195.48 Million ≈ $21.04 Million |
Skr38.55 Million ≈ $4.15 Million |
0.197x | +16.49% |
| 2011-12-31 | Skr169.82 Million ≈ $18.28 Million |
Skr28.75 Million ≈ $3.09 Million |
0.169x | -0.54% |
| 2010-12-31 | Skr179.99 Million ≈ $19.37 Million |
Skr30.64 Million ≈ $3.30 Million |
0.170x | +67.04% |
| 2009-12-31 | Skr169.94 Million ≈ $18.29 Million |
Skr17.32 Million ≈ $1.86 Million |
0.102x | +305.17% |
| 2008-12-31 | Skr134.11 Million ≈ $14.43 Million |
Skr3.37 Million ≈ $362.99K |
0.025x | +49.35% |
| 2007-12-31 | Skr127.44 Million ≈ $13.71 Million |
Skr2.15 Million ≈ $230.94K |
0.017x | -- |
About MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; an… Read more